Cargando…

Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease

BACKGROUND: Genomic sequencing in congenital heart disease (CHD) patients often discovers novel genetic variants, which are classified as variants of uncertain significance (VUS). Functional analysis of each VUS is required in specialised laboratories, to determine whether the VUS is disease causati...

Descripción completa

Detalles Bibliográficos
Autores principales: Fear, Vanessa S., Forbes, Catherine A., Shaw, Nicole C., Farley, Kathryn O., Mantegna, Jessica L., Htun, Jasmin P., Syn, Genevieve, Viola, Helena, Cserne Szappanos, Henrietta, Hool, Livia, Ward, Michelle, Baynam, Gareth, Lassmann, Timo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696868/
https://www.ncbi.nlm.nih.gov/pubmed/38049901
http://dx.doi.org/10.1186/s13287-023-03592-1
_version_ 1785154663391166464
author Fear, Vanessa S.
Forbes, Catherine A.
Shaw, Nicole C.
Farley, Kathryn O.
Mantegna, Jessica L.
Htun, Jasmin P.
Syn, Genevieve
Viola, Helena
Cserne Szappanos, Henrietta
Hool, Livia
Ward, Michelle
Baynam, Gareth
Lassmann, Timo
author_facet Fear, Vanessa S.
Forbes, Catherine A.
Shaw, Nicole C.
Farley, Kathryn O.
Mantegna, Jessica L.
Htun, Jasmin P.
Syn, Genevieve
Viola, Helena
Cserne Szappanos, Henrietta
Hool, Livia
Ward, Michelle
Baynam, Gareth
Lassmann, Timo
author_sort Fear, Vanessa S.
collection PubMed
description BACKGROUND: Genomic sequencing in congenital heart disease (CHD) patients often discovers novel genetic variants, which are classified as variants of uncertain significance (VUS). Functional analysis of each VUS is required in specialised laboratories, to determine whether the VUS is disease causative or not, leading to lengthy diagnostic delays. We investigated stem cell cardiac disease modelling and transcriptomics for the purpose of genetic variant classification using a GATA4 (p.Arg283Cys) VUS in a patient with CHD. METHODS: We performed high efficiency CRISPR gene editing with homology directed repair in induced pluripotent stem cells (iPSCs), followed by rapid clonal selection with amplicon sequencing. Genetic variant and healthy matched control cells were compared using cardiomyocyte disease modelling and transcriptomics. RESULTS: Genetic variant and healthy cardiomyocytes similarly expressed Troponin T (cTNNT), and GATA4. Transcriptomics analysis of cardiomyocyte differentiation identified changes consistent with the patient’s clinical human phenotype ontology terms. Further, transcriptomics revealed changes in calcium signalling, and cardiomyocyte adrenergic signalling in the variant cells. Functional testing demonstrated, altered action potentials in GATA4 genetic variant cardiomyocytes were consistent with patient cardiac abnormalities. CONCLUSIONS: This work provides in vivo functional studies supportive of a damaging effect on the gene or gene product. Furthermore, we demonstrate the utility of iPSCs, CRISPR gene editing and cardiac disease modelling for genetic variant interpretation. The method can readily be applied to other genetic variants in GATA4 or other genes in cardiac disease, providing a centralised assessment pathway for patient genetic variant interpretation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-023-03592-1.
format Online
Article
Text
id pubmed-10696868
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106968682023-12-06 Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease Fear, Vanessa S. Forbes, Catherine A. Shaw, Nicole C. Farley, Kathryn O. Mantegna, Jessica L. Htun, Jasmin P. Syn, Genevieve Viola, Helena Cserne Szappanos, Henrietta Hool, Livia Ward, Michelle Baynam, Gareth Lassmann, Timo Stem Cell Res Ther Research BACKGROUND: Genomic sequencing in congenital heart disease (CHD) patients often discovers novel genetic variants, which are classified as variants of uncertain significance (VUS). Functional analysis of each VUS is required in specialised laboratories, to determine whether the VUS is disease causative or not, leading to lengthy diagnostic delays. We investigated stem cell cardiac disease modelling and transcriptomics for the purpose of genetic variant classification using a GATA4 (p.Arg283Cys) VUS in a patient with CHD. METHODS: We performed high efficiency CRISPR gene editing with homology directed repair in induced pluripotent stem cells (iPSCs), followed by rapid clonal selection with amplicon sequencing. Genetic variant and healthy matched control cells were compared using cardiomyocyte disease modelling and transcriptomics. RESULTS: Genetic variant and healthy cardiomyocytes similarly expressed Troponin T (cTNNT), and GATA4. Transcriptomics analysis of cardiomyocyte differentiation identified changes consistent with the patient’s clinical human phenotype ontology terms. Further, transcriptomics revealed changes in calcium signalling, and cardiomyocyte adrenergic signalling in the variant cells. Functional testing demonstrated, altered action potentials in GATA4 genetic variant cardiomyocytes were consistent with patient cardiac abnormalities. CONCLUSIONS: This work provides in vivo functional studies supportive of a damaging effect on the gene or gene product. Furthermore, we demonstrate the utility of iPSCs, CRISPR gene editing and cardiac disease modelling for genetic variant interpretation. The method can readily be applied to other genetic variants in GATA4 or other genes in cardiac disease, providing a centralised assessment pathway for patient genetic variant interpretation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-023-03592-1. BioMed Central 2023-12-05 /pmc/articles/PMC10696868/ /pubmed/38049901 http://dx.doi.org/10.1186/s13287-023-03592-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fear, Vanessa S.
Forbes, Catherine A.
Shaw, Nicole C.
Farley, Kathryn O.
Mantegna, Jessica L.
Htun, Jasmin P.
Syn, Genevieve
Viola, Helena
Cserne Szappanos, Henrietta
Hool, Livia
Ward, Michelle
Baynam, Gareth
Lassmann, Timo
Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease
title Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease
title_full Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease
title_fullStr Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease
title_full_unstemmed Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease
title_short Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease
title_sort gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696868/
https://www.ncbi.nlm.nih.gov/pubmed/38049901
http://dx.doi.org/10.1186/s13287-023-03592-1
work_keys_str_mv AT fearvanessas geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease
AT forbescatherinea geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease
AT shawnicolec geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease
AT farleykathryno geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease
AT mantegnajessical geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease
AT htunjasminp geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease
AT syngenevieve geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease
AT violahelena geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease
AT cserneszappanoshenrietta geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease
AT hoollivia geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease
AT wardmichelle geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease
AT baynamgareth geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease
AT lassmanntimo geneeditingandcardiacdiseasemodellingfortheinterpretationofgeneticvariantsofuncertainsignificanceincongenitalheartdisease